Canaccord Genuity (CF) is rumoured to be weighing the sale of its UK wealth business, sending shares up 14%. Should a deal materialize, it would follow a series of transactions that brought AUM above $70B…

… which if done at a similar multiple to BMO’s $625M Burgundy deal, would put the price tag around £1B - in-line with a 12-16x multiple on last year’s EBITDA. At a quarter of CF’s revenue, the deal would be material…

… but assuming an adequate price, I’d like it. Everybody’s scrambling for scale in the industry, as evidenced by the $1.7B Guardian and $600M Richardson deals. That makes for a great off ramp for anyone not looking to play the same game.

Zigging when the market is zagging, with the same conviction that makes Strathcona (SCR) and Primaris (PMZ-U) interesting - and with a liquidity preference for minority owner HPS easing in 2026…

We have an ability to take them out. We have to come up with hundreds of millions of dollars to do that. So that’s a very good option. We could IPO the company. We could sell the company.

Daniel Daviau (CEO) - CF Q4’24 call

an official deal might not be so far away.

You might be interested in…

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.